NCT00138528已完成4 期
Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 55
- 试验地点
- 2
- 主要终点
- Change from baseline in circulating marker of inflammation (C-reactive protein) after 5 weeks
研究概览
简要总结
Other effects of fluvastatin are investigated in German patients with metabolic syndrome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent
- •Male and female patients, aged between 18 and 75 years
- •Metabolic syndrome according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII)
排除标准
- •History of heart failure
- •HIV positive
- •Other protocol defined inclusion and exclusion criteria may apply.
结局指标
主要结局
Change from baseline in circulating marker of inflammation (C-reactive protein) after 5 weeks
次要结局
- Change from baseline in oxidized low density lipoprotein cholesterol after 5 weeks
- Change from baseline in non high density lipoprotein cholesterol after 5 weeks
- Change from baseline in high density lipoprotein cholesterol after 5 weeks
- Change from baseline in low density lipoprotein cholesterol after 5 weeks
- Change from baseline in total cholesterol after 5 weeks
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic SyndromeDyslipidemiaNCT00385658Novartis75
已完成
不适用
Atorvastatin in polycystic ovary syndrome (PCOS)Polycystic ovary syndrome (PCOS)Nutritional, Metabolic, EndocrineOvarian dysfunctionISRCTN24474824Hull and East Yorkshire Hospital NHS Trust (UK)40
已完成
不适用
Differential Metabolic Effects of StatinsHypercholesterolemiaNCT00546559Gachon University Gil Medical Center
已完成
2 期
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsAntiphospholipid SyndromeNCT00674297Hospital for Special Surgery, New York41
已完成
4 期
Trial to Evaluate the Efficacy of Fluvastatin on Certain MarkersDyslipidemiaNCT00171262Novartis120